Thioredoxin Confers Intrinsic Resistance to Cytostatic Drugs in Human Glioma Cells

Bodo Haas1, Lena Schütte2,3, Maria Wos-Maganga4

  • 1Federal Institute for Drugs and Medical Devices, Kurt-Georg-Kiesinger-Allee 3, 53175 Bonn, Germany. bodo.haas@bfarm.de.

Insights

Thioredoxin (Trx) system inhibition overcomes chemoresistance in glioblastoma multiforme (GBM) by increasing apoptosis and reducing key survival proteins. Targeting Trx and PI3K pathways offers a novel therapeutic strategy for GBM treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Thioredoxin (Trx) overexpression contributes to chemotherapy resistance across tumor types, but its role in glioblastoma multiforme (GBM) is tissue-specific.
  • Understanding the Trx system's impact on intrinsic chemoresistance in GBM is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of the thioredoxin (Trx) system in the intrinsic chemoresistance of human glioblastoma multiforme (GBM) cells.
  • To evaluate the therapeutic potential of inhibiting the Trx system, alone or in combination with other pathways, for GBM treatment.

Main Methods:

  • Assessed GBM cell line and primary cell resistance to drugs using MTT assays.
  • Investigated Trx inhibition effects on apoptosis via proteome profiling and annexin V assays.
  • Utilized pharmacological Trx inhibition (PX-12) and TXNIP overexpression.

Main Results:

  • PX-12 reduced GBM cell viability, induced active caspase-3, and decreased AKT-kinase phosphorylation and β-catenin expression.
  • Trx inhibition restored sensitivity to cisplatin in GBM cells and sensitized primary cells to temozolomide.
  • Combined inhibition of Trx and phosphatidylinositide 3-kinase (PI3K) pathway led to significant cell death.

Conclusions:

  • The thioredoxin (Trx) system is a key mediator of chemoresistance in glioblastoma multiforme (GBM).
  • Trx inhibition, particularly in combination with PI3K pathway targeting, presents a promising therapeutic strategy for GBM.
  • The Trx system and PI3K pathway function sequentially, offering a novel drug target for glioblastoma treatment.

Related Concept Videos

Intrinsically Disordered Proteins02:18

Intrinsically Disordered Proteins

Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
19.5K
Intrinsically Disordered Proteins02:18

Intrinsically Disordered Proteins

2.8K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
12.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.6K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K
Resistance01:19

Resistance

When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
6.0K